Cortisol metabolism by 11 beta-hydroxysteroid dehydrogenase as a novel target in the treatment of inflammation- or immune-mediated bone loss: comment on the article by Makrygiannakis et al.
Wilckens
Thomas
T
Volkmann
Ariane
A
D042842:11-beta-Hydroxysteroid Dehydrogenases / Q000378:metabolism*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001168:Arthritis / Q000188:drug therapy* / Q000378:metabolism; D001862:Bone Resorption / Q000188:drug therapy* / Q000201:enzymology; D015536:Down-Regulation; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism*; D007249:Inflammation / Q000188:drug therapy* / Q000201:enzymology; D007270:Injections, Intra-Articular; D014222:Triamcinolone Acetonide / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D042842:11-beta-Hydroxysteroid Dehydrogenases; D014222:Triamcinolone Acetonide; C005900:triamcinolone hexacetonide; D006854:Hydrocortisone